NASDAQ:IMA | Insider Transactions | ImageneBio, Inc.

IMA Insider Transactions

68 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–68; provenance stays internal.

IMA insiders transaction timeline

PurchaseSale
2021-03-30: 23 purchases — FORMELA JEAN FRANCOIS, Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P. and 8 more2021-12-10: 8 sales — FORMELA JEAN FRANCOIS, Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P. and 5 more2021-12-13: 7 sales — FORMELA JEAN FRANCOIS, Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P. and 4 more2021-12-14: 7 sales — FORMELA JEAN FRANCOIS, Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P. and 4 more2022-01-10: 1 sale — Zhang Xiaoyan Michelle2022-01-11: 1 sale — Zhang Xiaoyan Michelle2022-06-22: 4 purchases — ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC and 1 more2022-06-23: 4 purchases — ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC and 1 more2022-06-24: 8 purchases — ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC and 1 more2025-07-25: 2 purchases — Bonita David P, Stampacchia Otello2025-12-24: 1 purchase — SLATTERY JOSEPH P2026-07-16: 1 sale — Lally Robert B2026-07-17: 1 sale — Lally Robert B2021-03-302026-07-17
Insider profileRoleDateTransactionSharesPrice
Lally Robert BPrincipal Accounting Officer2026-07-17Sale1,525$5.34
Lally Robert BPrincipal Accounting Officer2026-07-16Sale1,671$5.50
SLATTERY JOSEPH PDirector2025-12-24Purchase16,000.0$5.99
Bonita David PDirector2025-07-25Purchase83,611.0$29.9
Stampacchia OtelloDirector2025-07-25Purchase267,556.0$29.9
ORBIMED ADVISORS LLCDirector2022-06-24Purchase96,035.0$5.37
OrbiMed Capital GP VI LLCDirector2022-06-24Purchase96,035.0$5.37
OrbiMed Genesis GP LLCDirector2022-06-24Purchase96,035.0$5.37
ORBIMED ADVISORS LLCDirector2022-06-24Purchase65,965.0$4.37
OrbiMed Capital GP VI LLCDirector2022-06-24Purchase65,965.0$4.37
OrbiMed Genesis GP LLCDirector2022-06-24Purchase65,965.0$4.37
Bonita David PDirector2022-06-24Purchase96,035.0$5.37
Bonita David PDirector2022-06-24Purchase65,965.0$4.37
ORBIMED ADVISORS LLCDirector2022-06-23Purchase23,419.0$3.71
OrbiMed Capital GP VI LLCDirector2022-06-23Purchase23,419.0$3.71
OrbiMed Genesis GP LLCDirector2022-06-23Purchase23,419.0$3.71
Bonita David PDirector2022-06-23Purchase23,419.0$3.71
ORBIMED ADVISORS LLCDirector2022-06-22Purchase66,806.0$3.55
OrbiMed Capital GP VI LLCDirector2022-06-22Purchase66,806.0$3.55
OrbiMed Genesis GP LLCDirector2022-06-22Purchase66,806.0$3.55
Bonita David PDirector2022-06-22Purchase66,806.0$3.55
Zhang Xiaoyan MichelleChief Scientific Officer2022-01-11Sale964.0$12.0
Zhang Xiaoyan MichelleChief Scientific Officer2022-01-10Sale36.0$12.0
FORMELA JEAN FRANCOISDirector2021-12-14Sale5,959.0$14.0
Atlas Venture Fund XI, L.P.TenPercentOwner2021-12-14Sale5,959.0$14.0
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2021-12-14Sale5,959.0$14.0
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2021-12-14Sale5,959.0$14.0
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2021-12-14Sale5,959.0$14.0
Atlas Venture Associates XI, LLCTenPercentOwner2021-12-14Sale5,959.0$14.0
Atlas Venture Associates XI, L.P.TenPercentOwner2021-12-14Sale5,959.0$14.0
FORMELA JEAN FRANCOISDirector2021-12-13Sale8,330.0$14.64
Atlas Venture Fund XI, L.P.TenPercentOwner2021-12-13Sale8,330.0$14.64
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2021-12-13Sale8,330.0$14.64
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2021-12-13Sale8,330.0$14.64
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2021-12-13Sale8,330.0$14.64
Atlas Venture Associates XI, LLCTenPercentOwner2021-12-13Sale8,330.0$14.64
Atlas Venture Associates XI, L.P.TenPercentOwner2021-12-13Sale8,330.0$14.64
FORMELA JEAN FRANCOISDirector2021-12-10Sale11,989.0$15.03
Atlas Venture Fund XI, L.P.TenPercentOwner2021-12-10Sale11,989.0$15.03
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2021-12-10Sale11,989.0$15.03
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2021-12-10Sale11,989.0$15.03
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2021-12-10Sale11,989.0$15.03
Atlas Venture Associates XI, LLCTenPercentOwner2021-12-10Sale11,989.0$15.03
Atlas Venture Associates XI, L.P.TenPercentOwner2021-12-10Sale11,989.0$15.03
Zhang Xiaoyan MichelleChief Scientific Officer2021-12-10Sale1,000.0$14.76
FORMELA JEAN FRANCOISDirector2021-03-30Purchase125,000.0$16.0
Atlas Venture Fund XI, L.P.TenPercentOwner2021-03-30Purchase125,000.0$16.0
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2021-03-30Purchase125,000.0$16.0
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2021-03-30Purchase125,000.0$16.0
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2021-03-30Purchase125,000.0$16.0
Atlas Venture Associates XI, LLCTenPercentOwner2021-03-30Purchase125,000.0$16.0
Atlas Venture Associates XI, L.P.TenPercentOwner2021-03-30Purchase125,000.0$16.0
Bonita David PDirector2021-03-30Purchase48,400.0$16.0
Bonita David PDirector2021-03-30Purchase375,000.0$16.0
ORBIMED ADVISORS LLCDirector2021-03-30Purchase48,400.0$16.0
OrbiMed Capital GP VI LLCDirector2021-03-30Purchase48,400.0$16.0
OrbiMed Genesis GP LLCDirector2021-03-30Purchase48,400.0$16.0
ORBIMED ADVISORS LLCDirector2021-03-30Purchase375,000.0$16.0
OrbiMed Capital GP VI LLCDirector2021-03-30Purchase375,000.0$16.0
OrbiMed Genesis GP LLCDirector2021-03-30Purchase375,000.0$16.0
Bonita David PDirector2021-03-30Purchase48,400.0$16.0
Bonita David PDirector2021-03-30Purchase375,000.0$16.0
ORBIMED ADVISORS LLCDirector2021-03-30Purchase48,400.0$16.0
OrbiMed Capital GP VI LLCDirector2021-03-30Purchase48,400.0$16.0
OrbiMed Genesis GP LLCDirector2021-03-30Purchase48,400.0$16.0
ORBIMED ADVISORS LLCDirector2021-03-30Purchase375,000.0$16.0
OrbiMed Capital GP VI LLCDirector2021-03-30Purchase375,000.0$16.0
OrbiMed Genesis GP LLCDirector2021-03-30Purchase375,000.0$16.0